ask="4.00"
ask_size="300"
average_daily_volume="613402"
bid="2.00"
bid_size="100"
book_value="5.03"
change="+0.09"
change_from_200_day_moving_average="0.44"
change_from_50_day_moving_average="0.72"
change_from_52_week_high="-15.79"
change_From_52_week_low="1.81"
change_in_percent="+2.67%"
close="3.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.44"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.02"
ex_dividend_date="N/A"
float_shares="9594000"
high="3.57"
high_52_weeks="19.25"
last_trade_date="2/1/2017"
last_trade_price="3.46"
last_trade_size="1329"
last_trade_time="4:00pm"
low="3.28"
low_52_weeks="1.65"
market_capitalization="50.47M"
moving_average_200_day="3.02"
moving_average_50_day="2.74"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="3.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.41%"
percent_change_from_50_day_moving_average="+26.17%"
percent_change_from_52_week_high="-82.03%"
percent_change_from_52_week_low="+109.70%"
previous_close="3.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.67"
price_per_sales="1.99"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="2.18"
stock_exchange="NMS"
symbol="OREX"
volume="581968"
weeks_range_52="1.65 - 19.25"
